The challenge of very rare childhood cancers in developed and developing countries-Reference-Cited by-同舟云学术

The challenge of very rare childhood cancers in developed and developing countries

Published:2017-02-28 Issue:4 Volume:5 Page:331-341
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Ferrari Andrea¹,Schneider Dominik T.²,Bisogno Gianni³,Orbach Daniel⁴,Villarroel Milena⁵,Giron Veronica⁶,Rodriguez-Galindo Carlos⁷,Sorbara Silvia³,Magni Chiara¹,Chiaravalli Stefano¹,Casanova Michela¹,Cecchetto Giovanni⁸,Godzinski Jan⁹,Bien Ewa¹⁰,Stachowicz-Stencel Teresa¹⁰,Brennan Bernadette¹¹,Reguerre Yves¹²,Sultan Iyad¹³,Brecht Ines B.¹⁴

Affiliation:

1. Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy

2. Pediatrics Clinic, Dortmund Municipal Hospital, Dortmund, Germany

3. Hematology-Oncology Division, Department of Pediatrics, Padova University Hospital, Padova, Italy

4. Department of Pediatrics, Adolescent and Young Adult Oncology, Institut Curie, Paris, France

5. Oncology Unit, Hospital Luis Calvo Mackenna, Santiago, Chile

6. National Pediatric Oncology Unit/Unidad Nacional de Oncologia Pediatrica, Guatemala City, Guatemala

7. Department of Global Pediatric Medicine, St Jude Children‘s Research Hospital, Memphis, TN, USA

8. Pediatric Surgery, Department of Pediatrics, Padova University Hospital, Padova, Italy

9. Department of Pediatric Surgery, Marciniak Hospital, Wroclaw, Poland

10. Department of Pediatrics, Medical University, Gdansk, Poland

11. Department of Pediatric Oncology, Royal Manchester Children’s Hospital, Manchester, UK

12. Pediatric Hematology-Oncology Department, Centre Hospitalier Universitaire, Angers, France

13. Department of Pediatric Oncology, King Hussein Cancer Center, Amman, Jordan

14. Pediatric Hematology and Oncology, University of Tuebingen, Tuebingen, Germany

Funder

European Union

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2017.1298440

Reference68 articles.

1. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, SEER Program. NIH Pub. No. 99-4649. Bethesda (MD): National Cancer Institute; 1999. p. 1–15.

2. Cancer in Germany 2005/2006. Incidence and trends. 7th ed. Berlin: Robert Koch Institute and Association of Population-based Cancer Registries in Germany. 2010. p. 19–23. Results according to ICD-10. All cancer sites.

3. Rare malignant pediatric tumors registered in the German Childhood Cancer Registry 2001-2010

4. The challenge of very rare tumours in childhood: The Italian TREP project

5. Rare Cancers in Children – The EXPeRT Initiative: A Report from the European Cooperative Study Group on Pediatric Rare Tumors

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What rare cancers have in common. The making of lists of (very) rare cancers and the coordination of medical work;Frontiers in Sociology;2023-08-30

2. NUT carcinoma in children, adolescents and young adults;Bulletin du Cancer;2022-04

3. EXPeRT: The European Cooperative Study Group for Pediatric Rare Tumors;Pediatric Oncology;2022

4. Epidemiology and Differential Diagnosis of Cutaneous Tumors;Pediatric Oncology;2022

5. Rare Tumors in Children and Adolescents – the STEP Working Groupʼs Evolution to a Prospective Registry;Klinische Pädiatrie;2021-11-19